Decreased frequency of migraine headache and improved hyperhomocysteinemia were reported after folic acid treatment was administered to 16 children with migraine, hyperhomocysteinemia and MTHFR gene mutations, followed by a three-month follow-up. This evidence concerns the gene MTHFR and Headache.